Svb Wealth LLC Novartis Ag Transaction History

Svb Wealth LLC

$2.41 Billion
Q1 2025

A detailed history of Svb Wealth LLC transactions in Novartis Ag stock. As of the latest transaction made, Svb Wealth LLC holds 7,418 shares of NVS stock, worth $858,781. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,418

Previous 8,931 16.94%

Holding current value

$858,781

Previous $869,000 4.95%

% of portfolio

0.03%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$97.14 - $115.57 $146,972 - $174,857	-1,513 Reduced 16.94%	7,418 $826,000
Q4 2024 Feb 05, 2025	BUY	$96.78 - $117.18 $864,342 - $1.05 Million	8,931 New	8,931 $869,000
Q2 2024 Aug 06, 2024	SELL	$92.57 - $107.37 $167,921 - $194,769	-1,814 Reduced 13.79%	11,345 $1.21 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $280,665 - $319,552	-2,946 Reduced 18.29%	13,159 $1.27 Million
Q4 2023 Jan 30, 2024	BUY	$92.27 - $101.54 $47,611 - $52,394	516 Added 3.31%	16,105 $1.63 Million
Q3 2023 Oct 23, 2023	SELL	$94.73 - $105.13 $3,978 - $4,415	-42 Reduced 0.27%	15,589 $1.59 Million
Q2 2023 Jul 24, 2023	SELL	$92.52 - $104.91 $18,411 - $20,877	-199 Reduced 1.26%	15,631 $1.58 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $47,377 - $54,943	-592 Reduced 3.6%	15,830 $1.46 Million
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $105,845 - $129,620	-1,401 Reduced 7.86%	16,422 $1.49 Million
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $15,668 - $18,324	-210 Reduced 1.16%	17,823 $1.36 Million
Q2 2022 Aug 16, 2022	BUY	$80.52 - $93.75 $301,788 - $351,375	3,748 Added 26.24%	18,033 $1.52 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $147,482 - $166,831	1,841 Added 14.79%	14,285 $1.25 Million
Q4 2021 Feb 15, 2022	SELL	$79.7 - $88.13 $101,537 - $112,277	-1,274 Reduced 9.29%	12,444 $1.09 Million
Q3 2021 Nov 09, 2021	SELL	$81.78 - $95.14 $34,347 - $39,958	-420 Reduced 2.97%	13,718 $1.12 Million
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $76,801 - $84,829	-901 Reduced 5.99%	14,138 $1.29 Million
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $1.26 Million - $1.49 Million	-15,096 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $44,031 - $53,258	564 Added 3.88%	15,096 $1.43 Million
Q3 2020 Nov 10, 2020	BUY	$82.14 - $91.0 $323,713 - $358,631	3,941 Added 37.21%	14,532 $1.26 Million
Q2 2020 Aug 05, 2020	SELL	$80.93 - $91.1 $53,818 - $60,581	-665 Reduced 5.91%	10,591 $925,000
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $121,340 - $170,000	1,717 Added 18.0%	11,256 $928,000
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $92,700 - $104,811	1,099 Added 13.02%	9,539 $904,000
Q3 2019 Nov 01, 2019	BUY	$85.54 - $94.26 $4,105 - $4,524	48 Added 0.57%	8,440 $733,000
Q2 2019 Jul 10, 2019	BUY	$75.4 - $92.8 $27,068 - $33,315	359 Added 4.47%	8,392 $766,000
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $116,218 - $132,929	-1,543 Reduced 16.11%	8,033 $772,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $110,490 - $123,030	-1,500 Reduced 13.54%	9,576 $821,000
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $80,997 - $93,690	-1,210 Reduced 9.85%	11,076 $954,000
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $381,800 - $431,503	-5,882 Reduced 32.38%	12,286 $929,000
Q1 2018 May 11, 2018	SELL	$70.39 - $84.15 $135,219 - $161,652	-1,921 Reduced 9.56%	18,168 $1.47 Million
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $97,717 - $104,891	-1,351 Reduced 6.3%	20,089 $1.69 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $1.59 Million - $1.66 Million	21,440	21,440 $1.84 Million

Others Institutions Holding NVS

# of Institutions

1,523

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account